Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Klotho Neurosciences, Inc. (KLTO) had Stock-Based Compensation of $1.53M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.90M |
|
-- |
|
-- |
|
$1.85M |
|
$-1.85M |
|
$-1.04M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-2.90M |
|
$-1.85M |
|
$-1.85M |
|
59.42M |
|
59.42M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$7.77M |
|
-- |
|
$2.30M |
|
$10.07M |
|
$0.09M |
|
-- |
|
$0.05M |
|
$0.15M |
|
$9.93M |
|
$7.63M |
|
$9.93M |
|
70.33M |
|
| Cash Flow Statement Financials | |
$-4.61M |
|
-- |
|
$11.89M |
|
$0.06M |
|
$7.35M |
|
$7.28M |
|
|
Stock-Based Compensation |
$1.53M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
83.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-29.17% |
|
-37.96% |
|
-28.75% |
|
-29.17% |
|
$0.14 |
|
$-0.08 |
|
$-0.08 |
|